118 related articles for article (PubMed ID: 11129335)
1. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.
Gutzmer R; Herbst RA; Mommert S; Kiehl P; Matiaske F; Rütten A; Kapp A; Weiss J
Hum Genet; 2000 Oct; 107(4):357-61. PubMed ID: 11129335
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1.
Ishii S; Han S; Shiiba K; Mizoi T; Okabe M; Horii A; Nagura H; Matsuno S; Sasaki I
Int J Clin Oncol; 2001 Aug; 6(4):201-4. PubMed ID: 11706558
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
6. A search for evidence of somatic mutations in the NF1 gene.
John AM; Ruggieri M; Ferner R; Upadhyaya M
J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis at the NF1 locus in astrocytic brain tumors.
Jensen S; Paderanga DC; Chen P; Olson K; Edwards M; Iavorone A; Israel MA; Shannon K
Cancer; 1995 Aug; 76(4):674-7. PubMed ID: 8625164
[TBL] [Abstract][Full Text] [Related]
10. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.
Cacev T; Radosević S; Spaventi R; Pavelić K; Kapitanović S
Gut; 2005 Aug; 54(8):1129-35. PubMed ID: 15840687
[TBL] [Abstract][Full Text] [Related]
11. Alterations of microsatellites in neurofibromas of von Recklinghausen's disease.
Ottini L; Esposito DL; Richetta A; Carlesimo M; Palmirotta R; Verí MC; Battista P; Frati L; Caramia FG; Calvieri S
Cancer Res; 1995 Dec; 55(23):5677-80. PubMed ID: 7585653
[TBL] [Abstract][Full Text] [Related]
12. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
Mahalingam M
Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
[TBL] [Abstract][Full Text] [Related]
13. Status of the NF1 tumor suppressor locus in uveal melanoma.
Foster WJ; Fuller CE; Perry A; Harbour JW
Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
[TBL] [Abstract][Full Text] [Related]
14. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
Xu W; Mulligan LM; Ponder MA; Liu L; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1992 Jun; 4(4):337-42. PubMed ID: 1377942
[TBL] [Abstract][Full Text] [Related]
15. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients.
De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E
Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335
[TBL] [Abstract][Full Text] [Related]
16. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
18. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
Sawada S; Florell S; Purandare SM; Ota M; Stephens K; Viskochil D
Nat Genet; 1996 Sep; 14(1):110-2. PubMed ID: 8782831
[TBL] [Abstract][Full Text] [Related]
19. NF1 Mutations Are Common in Desmoplastic Melanoma.
Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
